Showing posts with label Market Trends. Show all posts
Showing posts with label Market Trends. Show all posts

Thursday, 12 January 2017

Needle Free Drug Delivery Devices Market size and Key Trends in terms of volume and value 2015-2023

This report on the needle free drug delivery devices market analyzes the current and future scenario of the global market. Large number of chronic pain and diabetes sufferers is increasing the usage of needle free drug delivery devices. Less pain and consistency in drug delivery are the major drivers of the global needle free drug delivery devices market.
The needle free drug delivery devices market report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to the segments based on application and geography. A detailed qualitative analysis of drivers and restraints of the market and opportunities has been provided in the market overview section. In addition, the section comprises Porters Five Forces Analysis to understand the competitive landscape in the market. This section of the report also provides market attractiveness analysis, by geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global needle free drug delivery devices market.
Based on technology, the market has been segmented into jet injectors and competing needle-free technologies. The competing needle-free technologies segment has been further divided into novel needle technology, inhaler technology, and transdermal patch technology. Novel needle technology includes micro-needle and pen needle. The market segments have been analyzed based on available approved products, cost-effectiveness, and preference for technologies by physicians and patients. The market size and forecast for each of these segments have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year.
Based on application, the needle free drug delivery devices market has been segmented into five major categories: vaccine delivery, pain management, insulin delivery, pediatric injections, and others. Other applications of needle free drug delivery devices include angina, hypertension, and other medical conditions. The market segments have been extensively analyzed based on prevalence of the diseases, available treatment, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment have been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023, considering 2014 as the base year.
Geographically, the global needle free drug delivery devices market has been categorized into five major regions and the key countries in the respective region: North America (the U.S., Canada), Europe (the U.K., Germany, and Rest of Europe), Asia Pacific (Japan, China, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2013 to 2023, along with their respective CAGRs for the forecast period from 2015 to 2023, considering 2014 as the base year. The research study also covers the competitive scenario in these regions.
The report also profiles major players in the global needle free drug delivery devices market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include Zogenix, Inc., 3M Health Care, Antares Pharma, Inc., Glide Pharmaceutical Technologies Ltd., Injex Pharma AG, and Pharmajet, Inc.

Operating Room Equipment Market: Business Challenges, Emerging Technologies & Competitive Landscape

The operating room equipment market report evaluates each of the segments and its sub-categories in detail for market trends, recent developments, outlook, and opportunities. The market overview section of the report explores market dynamics such as drivers, restraints, and opportunities that currently have strong impact on the global operating room equipment market and could influence the market in future as well. Market attractiveness analysis has been provided in the market overview section in order to explain the intensity of competition between leading market players operating across the globe. All these factors would help market players to take strategic decisions in order to strengthen their market positions and increase their correspondent market shares.
The recommendations section included in the report would assist existing market players in targeting all major stakeholders in this industry such as companies and hospitals. The report also profiles major players in the global operating room equipment market based on various attributes such as company details, business overview, financial facts, business strategies and recent developments.
The operating room equipment market report analyzes the current and future prospects of the global market. The operating room equipment market comprises movable imaging systems, biomedical systems, endoscopes, anesthesia systems, operating tables, operating room lights, surgical imaging displays, operating room integration systems, surgical booms, and microscopes. The growth of the overall market is due to rise in number of hospitals, growing number of ambulatory surgical centers, surge in demand for hybrid operating rooms, growing number of regulations for operating room equipment, and increase in number of geriatric population coupled with high number of surgeries worldwide. Globally, the operating room equipment market has been experiencing steady growth and the trend is expected to continue during the forecast period from 2015 to 2023.
Based on product type, the operating room equipment market has been segmented into movable imaging systems, biomedical systems, endoscopes, anesthesia systems, operating tables, operating room lights, surgical imaging displays, operating room integration systems, surgical booms, and microscopes. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of US$ Mn for each segment has been provided for the period from 2013 to 2023. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2015 to 2023.
Additional information, such as recent developments in operating room equipment, market dynamics, and value chain analysis, in the market overview chapter provides details to assist new and existing players to venture and explore latent market opportunities in the near future. This report provides in-depth analysis of the global operating room equipment market. The stakeholders for this report include companies involved in the research and development and application. In order to provide a snapshot of this market to stakeholders, this report includes an executive summary section, which summarizes the market size, trends, and competition for different regions.
Major drivers of demand and growth of the operating room equipment market include growing number of ambulatory surgical centers, product innovations driven by advances in technology, rising demand for hybrid operating room, and increase in the number of surgeries. Apart from this, innovations related to patient handling techniques will propel the operating room equipment market in the next few years. Major restraints of the market include high cost of operating room equipment. However, the report also highlights various opportunities that are expected to boost market growth during the forecast period.
The operating room equipment market report also includes recommendations section that will assist new companies to establish their presence and existing players to expand their market shares. Key players in the operating room equipment market include Allen Medical (Hill ROM), GE Healthcare, KARL STORZ GmbH & Co. KG, Mizuho OSI, Maquet Holding B.V. & Co. KG (Getinge AB), Olympus Corporation, Philips Healthcare, Siemens Healthcare, Skytron, LLC, Steris Corporation, Stryker Corporation, and TRUMPF GmbH + Co. KG.

Dental Laboratories Market to 2023: Trends, Business Strategies and Opportunities with Key Players Analysis

Global Dental Laboratories Market: Overview
The global market for dental laboratories is undergoing a widespread transformation. The rising prevalence of oral disorders, coupled with the growing awareness regarding oral care and hygiene, is driving this market substantially. In addition to this, the increase in cosmetic surgeries of teeth, fueled by the surging interest of consumers towards personality grooming, is expected to support this market considerably over the forecast period.
According to Transparency Market Research (TMR), the global market for dental laboratories stood at US$12.9 bn in 2014. Rising at a CAGR of 4.90% during the period from 2015 to 2023, the market is likely to reach US$20.2 bn by the end of 2023.
In this research report, the worldwide market for dental laboratories has been studied with a microscopic view in an attempts to provide a detailed market assessment on the basis of its past performance and its present status. The recent prominent trends and the lucrative growth opportunities within this market have also been examined thoroughly to identify its future status in this research study.
Global Dental Laboratories Market: Trends and Opportunities
The rise in the aesthetic consciousness of consumers across the world is having a significant influence on the global market for dental laboratories. The substantial rise in the disposable income of people has boosted their spending power, fueling their interest in facial beauty, especially in their dental care. This, as a result, is adding considerably to the worldwide dental laboratories market.
Global Dental Laboratories Market: Geographical Analysis
On the basis of geography, the global market for dental laboratories is spread across North America, Asia Pacific, Europe, and the Rest of the World. The U.S. and Canada are the key domestic markets for dental laboratories in North America. The Europe market for dental laboratories stretches across Italy, the U.K., France, Germany, Spain, and the Rest of Europe. Japan, China, and the Rest of Asia Pacific drives the Asia Pacific market while Latin America and the Middle East and Africa are the main regional markets in the Rest of the World.
Europe has acquired the leading position in this market and is closely followed by North America. The increasing number of community-based oral health programs, conducted across Europe, which focus on delivering preventive treatments, increasing awareness, and improving patient education about various dental procedures and artificial products, has contributed significantly to the growth of the Europe market for dental laboratories. Researchers expect this regional market to remain on top over the next few years.
Asia Pacific, on the other hand, is expected to present attractive growth opportunities to market players in the years to come. The increasing trend of dental tourism and the substantial surge in the export demand for periodontics, orthodontic, bridges, crowns, and implants in emerging economies, such as India and China, are projected to propel the Asia Pacific dental laboratories market in the next few years.
Companies Mentioned in the Research Report
Sirona Dental Systems, Henry Schein Inc., Patterson Companies Inc., 3M Health Care, Keating Dental Arts, Modern Dental Laboratory Co. Ltd., Institut Straumann AG, Shofu Inc., National Dentex Corp., Danaher Corp., Yenadent Ltd. Sti., Dentcare Dental Lab, and Zimmer Biomet Holdings Inc. are some of the leading players in the global market for dental laboratories.

Nebulizers Market: Large Participant Pool Makes for Fragmented Competitive Landscape

A nebulizer is an electrically powered or battery operated instrument that converts liquid medication into mist. Nebulizer is one of the preferred choices for the treatment of asthma, cystic fibrosis (CFTR) and COPD (chronic obstructive pulmonary disease). This facilitates penetration of the medicine into the lungs of patients when inhaled through the mouth or a face mask. The nebulizers market in India is dominated by various devices powered by electric current and rechargeable batteries. Increasing prevalence of various respiratory disorders such as asthma, COPD, and CFTR coupled with rising geriatric population and deteriorating air quality in major cities of India fuel the growth of the nebulizers market in India.
This research report explains various advancements occurring in this market and analyzes the nebulizers market in India by products and geography. This report comprises an elaborate executive summary, which includes a market snapshot that provides overall information of various segments and sub-segments that are provided in the report. Moreover, executive summary comprises waterfall chart representing the nebulizers market in India by type in terms of INR Mn in 2014 which is drawn on the basis of most attarctive segment of the market. Comparative analysis has also been included in the executive summary that demonstrates the percentage market share of each segments in 2014 and 2023 respectively.
This report provides in-depth analysis of the nebulizers market in India. The stakeholders for this report include companies involved in the manufacture of nebulizers, kits and accessories and supply to to the hospitals and homes. For providing a snapshot of this market to the stakeholders, executive summary section is included in this report, which summarizes the market size, trends and competition in different zones of India. The market overview section of this report analyzes market dynamics such as drivers, restraints and opportunities that influence the nebulizers market in the current and future scenario. Market share analysis among the market players is analyzed to signify percentage share of the major players operating in the nebulizers market in India. All these factors will help the market players to decide about the business strategies and plans to be incurred in future for strengthening their position in India.
Based on the product, the nebulizers market in India has been segmented as pneumatic nebulizer, ultrasonic nebulizers, mesh nebulizer and nebulizer kits. Pneumatic nebulizer comprises pressurized gas supply that assists in pushing medication toward the mouth. Compressed gas is delivered through a jet (valve) that creates negative pressure on the medication tank to release the medication. An ultrasonic nebulizer uses electric current to produce high frequency vibrations in a container of fluid (medications) to break up the fluid into aerosol particles. Mesh nebulizers create vibrations (piezo) that enable the flow of liquid formulation (medicine) through a fine mesh (aperture plate) to develop aerosol medication.
Region wise, the nebulizer market in India has been differentiated into five major regions: North Zone, South Zone, East Zone, West Zone, and Central/ Zone. A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the India nebulizers market in various regions has been provided in this section. The report provides market estimation of nebulizers market in India in terms of revenue (INR Mn) for all the segments and sub segments with CAGR % for period 2015 to 2023, considering 2014 as the base year. The report also provides the volume of nebulizers for all the segments and sub segments with CAGR % for period 2015 to 2023. Furthermore, the report incorporates market attractiveness analysis by product category that depicts the most attractive product segment in India during the forecast period from 2015 to 2023.
This report also includes recommendations section that will assist new companies in establishing their presence and market players in expanding their market share in the nebulizers market in India. The report concludes with the company profile section which includes company overview, financial overview, product portfolio, business strategies and recent developments for market players. The major players that are profiled in the report include Omron Healthcare, Philips Healthcare, CareFusion Corporation (BD), Nuilfe, Bhasins and Sons, Respirotec are among others.

Thursday, 5 January 2017

Alarming Prevalence of Cardiovascular Diseases to Boost Global Cardiac Rehabilitation Market

Cardiovascular diseases have surfaced as a major concern in the medical and healthcare industry. As elderly people are more prone to these diseases, the significant increase in the global geriatric population has augmented the risk of their prevalence, which consequently, is having a phenomenal impact on the demand for cardiac rehabilitation measures across the world.
According to Transparency Market Research (TMR), the global market for cardiac rehabilitation offered an opportunity of US$1.0 bn in 2015. Boosted by the rising incidence of cardiac arrest, heart failure, and other cardiovascular diseases, the opportunity of this market is likely to expand at a CAGR of 5.40% during the period from 2016 to 2024 and reach a value of US$1.6 bn by the end of 2024.
Through this blog post, analysts at TMR are answering some of the most important questions about the global cardiac rehabilitation market:
What are the key driving forces behind the growth of the global cardiac rehabilitation market?
The surge in the prevalence of cardiovascular diseases across the world is the key factor behind the tremendous growth of the global market for cardiac rehabilitation. Apart from this, the technological advancements in the medical and healthcare infrastructure, rise in the purchasing power of consumers, and the awareness about the role of cardiac rehabilitation in the treatment of various cardiovascular diseases are also boosting this market considerably.
Which of the geographical segments is likely to dominate the global market for cardiac rehabilitation?
North America, which has been leading the global market for cardiac rehabilitation over the last few years due to the high disposable income of people, enabling them to spend on expensive treatment services, is likely to continue its leading streaks in the forthcoming years with a majority share.
Other regional markets, specifically Europe and Asia Pacific are also projected to witness strong growth over the next few years, thanks to the growing awareness about cardiac rehabilitation and its advantages. The advancing technology and the state-of-art medical and healthcare infrastructure are expected to support the Europe market for cardiac rehabilitation while the Asia Pacific market is likely to gain from the improving economic conditions in developing nations. Between 2016 and 2024, the market for cardiac rehabilitation is estimated to expand at a CAGR of 6.80%, higher than all other regional markets.
What are the main strategies market players are adopting for the development of their businesses?
Mostly, the key players are relying on product innovation for business development. Price competition is another significant strategy, participants are adopting to gain an edge over their competitors. Going forward, the leading companies are expected to shift their focus towards strategic alliances, mergers, and acquisitions to enhance their visibility in the global market.

Friday, 30 December 2016

Big Expectations for the future of Dental Laboratories Market

Transparency Market Research has published a new market report titled, “Dental Laboratories Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.” According to the report, the global dental laboratories market was valued at US$ 12,991.6 Mn in 2014 and is projected to expand at a CAGR of 4.9% from 2015 to 2023 to reach US$ 20,234.1 Mn in 2023.
Dental laboratories are an amalgamation of art, science, and technology required for designing and manufacturing of products as a replacement of natural teeth. The scope of the research encompasses development of products such as crowns, bridges, caps, veneers, and other orthodontic splints and appliances essential to protect and straighten teeth. Similar to other areas/domains of the health care industry, the dentistry segment has witnessed significant growth over the past few years. Introduction of novel technologies and innovative materials have also attributed to the evolution of the dental laboratories market.
Geographically, the global dental laboratories market has been segmented into four major regions: North America, Europe, Asia Pacific, and Rest of the World. Each region has been further analyzed and estimated for major contributing countries. For instance, North America includes the U.S. and Canada. Europe has been sub-categorized into the U.K., Germany, France, Spain, Italy, and Rest of Europe. Asia Pacific includes China, Japan, and Rest of Asia Pacific. Rest of the World has been studied and segmented into Latin America and Middle East & Africa.
Europe accounted for the lion’s share of the global dental laboratories market in 2014, followed by North America. A number of community-based oral health programs are conducted across the European Union that focus on delivery of preventive treatment, increase awareness, and enhance patient education toward various procedures and artificial dental products, which over the past few years have contributed to the growth of the dental laboratory industry. However, Asia Pacific is expected to outperform the two major contributing regions during the forecast period from 2015 to 2023. Growth of the market in Asia Pacific is primarily driven by rising trend of dental tourism and increase in the number of laboratories established in the last five years. Moreover, the market is projected to expand at a substantial growth rate due to increase in export demand for dental orthodontic, periodontics, crowns, bridges, and implants from emerging markets such as India and China. Health care provision in Africa is challenged by the burden of poverty and underdevelopment, with 80% of the population falling into the lowest socioeconomic category. Lack of financial and technical resources, shortage of health personnel, and insufficient primary health care delivery make it hard for most of the population of Africa to access basic health services. Shortage of oral health personnel is a common problem in Africa, as the average dentist to population ratio is approximately 1:150000 compared to 1:2000 in most developed economic countries.
Lack of proper reimbursement and high operational cost are the major restraints of the global dental laboratory industry. To operate a dental laboratory, around 40% to 60% of what a dentist pays goes toward the expense of running a modern dental practice. Additionally, pay for rent or mortgage payments on their office space, payroll for hygienists, office managers and receptionists, health insurance, taxes, supplies, business insurance, and technology are the other expense burdens on laboratory owners. High operational cost, intense competition, and restricted geographical reach are among the primary reasons for closure of large number of dental laboratories in the past few years that is common in both developed and emerging markets.
Advent of CAD/CAM technology has significantly reduced the design and manufacturing time for dental prosthesis such as crowns and bridges. 3D imaging techniques have improved patient diagnosis and procedure planning; hence are considered to be other factors driving sustained growth and demand for dental laboratories and services offered to dentists. Rising costs and declining insurance reimbursements have created high demand for outsourced dental laboratories work. Currently, approximately 40% to 50% dental laboratories in the U.S. use off-shore laboratory services to produce components and/or complete dental laboratory services such as crowns, bridges, single porcelain fused to gold, complete dentures, partials, and frameworks.
Key players operating in this market are 3M Health Care, Danaher Corporation, Dentcare Dental Lab, Henry Schein, Inc., Institut Straumann AG, Keating Dental Arts, Modern Dental Laboratory Co., Ltd., National Dentex Corporation, Patterson Companies, Inc., Shofu, Inc., Sirona Dental Systems, and Yenadent Ltd. Sti.

Advanced (3D/4D) Visualization Systems Market: Future market projections for forthcoming years

The global advanced 3D/4D visualization systems market is dominated by some of the key companies such as Philips Healthcare, Toshiba, Siemens Healthcare, and GE Healthcare. These top companies collective dominated the global advanced 3D/4D visualization systems market by accounting for 39.4% in 2015. The global advanced 3D/4D visualization systems market is highly dynamic and competitive in nature with many new companies aiming to enter the competition. Going forward, the demand for higher technology 3D/4D visualization systems is expected to increase, which will increase the level of competition. Transparency Market Research (TMR), in a new report on this global market, states that the market is expected to be affected by the presence of substitutes for 3D/4D visualization systems.
The global advanced 3D/4D visualization systems market is predicted to reach US$3,280.0 mn by 2024. Based on platform, the global advanced 3D/4D visualization systems market is expected to be dominated by the CT segment as this segment is predicted to reach US$954.5 by 2024. Considering the rising demand, key companies are expected to introduce new 3D and 4D visualization systems in the global market so as to maintain their dominance throughout the forecast period.
Hospitals to Lead Demand for Advanced 3D/4D Visualization Systems
By end user, the global advanced 3D/4D visualization systems market was led by the hospital segment in 2015 and this segment is predicted to maintain its dominance throughout the forecast period. The hospital segment is expected to reach US$2,630.9 mn by 2024 owing to the rising number of hospitals demanding advanced 3D/4D visualization systems. Based on application, neurology led the global advanced 3D/4D visualization systems market in 2015. This segment is expected to maintain its dominance by 2024, to reach US%875.8 mn. The rising use of 3D and 4D visualization systems for conducting oncology procedures is predicted to propel this segment. Based on region, North America dominated the global advanced 3D/4D visualization systems market in 2015 and is predicted to maintain its dominance. The North America advanced 3D/4D visualization systems market is expected to reach US$1,052.9 by 2024.
Rising Medical Procedures to Propel Demand for 3D/4D Visualization Systems
The number of neurology, cardiology, oncology, and many other medical procedures is increasing in many of the emerging nations. “Medical procedures are conducted by using advanced quality 3D and 4D visualization systems, which is a boon for the global market,” says a TMR analyst. Advancements in the existing visualization systems and the rise in the demand for digitizing patient data are two of the other factors expected to benefit the global advanced 3D/4D visualization systems market.
Emergence of 5D Technology can Challenge Global Market
The introduction of 5D visualization technology has become possible because of the introduction of advanced technology. This is expected to be the biggest challenge for the global advanced 3D/4D visualization systems market. The high cost of equipment and the already existing investments in costly medical equipment can also hinder the growth of the global market for advanced 3D/4D visualization systems.
Untapped Market to Create Growth Opportunities
Emerging technologies and the untapped market can create new growth opportunities for the startups and key companies operating in the global advanced 3D/4D visualization systems market. The evolution of new advanced application for AV software is likely to benefit the global market for advanced 3D/4D visualization, says a TMR analyst.
This information is based on the findings of a report published by Transparency Market Research titled “Advanced (3D/4D) Visualization Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016–2024.”

Hearing Aids Market: High Prevalence of Hearing Impairment among Adults Fuels Demand

Early detection and treatment of hearing loss can mitigate the severity of deafness and could improve the condition of those suffering from the condition. As per World Health Organization, in 2015 the hearing aid production globally, hardly met 10% of the total need and a meager 3% of demand across developing countries. This provides the global hearing aids market with substantial opportunities to gain from in the forthcoming years.
As per Transparency Market Research (TMR), the global hearing aids market is expected to reach US$7.01 bn by 2024, from US$4.7 bn in 2015. Between 2016 and 2024, the global hearing aids market is thus expected to surge at a CAGR of 4.5%.
Increasing Geriatric Population and Awareness to Boost Sales of Hearing Aids
As aged people are more prone to develop hearing impairment, the sales of hearing aids are directly impacted by the current geriatric demographic dynamics in worldwide. In the last of few years, the awareness level among patients and their families regarding hearing impairment has considerably increased. This, combined with the recent advances in the hearing aid technology, is boosting sales of hearing aids worldwide. Furthermore, the advent of rechargeable hearing aids with long lasting and quick charging features will also augment the market’s growth.
Opportunities for the Market in Europe to be Most Lucrative
Regionally, Europe has been exhibiting the most attractive opportunities for companies in the hearing aids market. It emerged dominant with a share of 39% in the global market in 2015. The presence of a large pool of aged people across Western Europe and the increasing willingness among consumers to spend on advanced medical devices have helped Europe attain the lead in the global hearing aids market. The fact that several of the prominent names in the industry are domiciled in the region has also augured well for the market. TMR has pegged the value of the Europe hearing aids market at US$1.8 bn in 2015 and forecasts it to reach US$2.6 bn by the end of 2024, rising at a CAGR 4.1% from 2015 to 2024.
However, the market in Asia Pacific is expected to grow at a fast pace during the forecast period. The prevalence of considerably high unmet medical needs and the rising investment in the health care infrastructure create immense opportunities for sale of hearing aids in Asia Pacific. Besides this, governments across emerging economies are making considerable efforts to educate people about conditions such as health impairments have fuelled demand for hearing aids in the region. As per TMR, the regional market is expected to rise at a CAGR of 5.2% between 2016 and 2024.
Increasing Incidence of Hearing Loss in Children to Necessitate Development of New Products
By end user, the global hearing aids market is bifurcated into adult and pediatric. Of these, the adult segment held approximately 94.83% of the market in 2015.The incidence of hearing impairment is higher in developing and under-developed countries because of the high geriatric population in these countries. However, in the forecast period growth exhibited by the pediatric segment is expected to be faster due to the rising prevalence of hearing loss among children.
Key players in this market are Sonova AG (Switzerland), William Demant Holding (Denmark), Siemens Healthcare (Germany), GN ReSound A/S (Denmark), Starkey (U.S.), and Widex A/S (Denmark), among others.

Thursday, 22 December 2016

Implantable Medical Devices Market is expected to rise to US$49.8 bn in 2024

Transparency Market Research estimates that the global implantable medical devices market will witness expansion at a healthy 4.9% CAGR over the period between 2016 and 2024. At this pace, the market, which had a valuation of US$32.3 bn in 2015, is expected to rise to US$49.8 bn by 2024. Of the key materials used for manufacturing medical implants, titanium is presently the most preferred but is expected to lose its prominence to other options such as titanium alloys and zirconium. Over the period between 2016 and 2024, the market for titanium implants is expected to expand at a 4.7% CAGR. The markets for titanium alloy implants and zirconium implants are expected to expand at 5.5% and 6.4% CAGR over the same period, respectively.
The global implantable medical devices market features a largely consolidated competitive landscape, with the top five companies accounting for a share of more than 50% in 2015, reports TMR in a recent report. These companies, including Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic plc, Institut Straumann AG, hold sway owing to innovation, rapid introduction of newer and more effective product varieties, and presence across several key regional markets. Being a technology- and research-intensive field, governed by stringent approval regulations, the implantable medical devices market faces a low threat of new entrants in the next few years. However, the introduction of more promising substitutes to traditionally used materials is expected to intensify competition.
Rising Prevalence of Chronic Degenerative Disease and Dental Problems to Stimulate Demand for Implantable Medical Devices Globally
A plethora of factors are boosting the global consumption of medical implantable devices. Some of the chief ones of these are the rising numbers of people suffering from chronic degenerative diseases such as arthritis and cardiovascular issues and the high prevalence of dental problems, which could require orthodontic and periodontics interventions. While busy lifestyles, unhealthy dietary habits, lack of physical activities, and rising geriatric population are triggering chronic health diseases, the rising intake of junk/fast food is leading to the increased incidences of dental issues. Over the next few years, these factors are expected to arise as high-impact drivers of the global implantable medical devices.
Along with these factors, the rising prevalence of a number of congenital diseases and the increased awareness and consciousness regarding body’s appearance, and the alleged boost to self-esteem that cosmetic surgeries bring, have also been underlined as the key drivers of the global implantable medical devices market. The increased awareness regarding body aesthetics has given a huge boost to the market for dental surgeries involving implantations, thus driving the global implantable medical devices market.
Concerns Regarding Corrosion, Developments in Surgical Field Threaten to Hurt Demand for Conventional Implants
Studies have demonstrated that implants made from materials such as nickel and chromium are prone to corrosion and can trigger cancers. Implants made from cobalt alloy are known to pose risks to human health owing to in vivo ion release; polyethylene implants could be a potential trigger for bone lysis and localized tissue ruptures. Owing to the potential health issues that many varieties of implants cause, patients are more prone to opt for other alternatives. Along with this, the vast developments in the surgical field could also stimulate the consumer to prefer surgeries that promise minimal risk to health.
Moreover, the high costs of medical implants and the concerns regarding post-implantation infections, which may add to the overall cost of implanting a medical device in the body, are also restraining the overall growth prospects of the global implantable medical devices market to a certain extent.
This review is based on a recent report by Transparency Market Research, titled “Implantable Medical Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2016 - 2024.”

Tuesday, 20 December 2016

Increasing Number of Participants in India Nebulizers Market will Compete Feverishly on Price, says TMR

Thanks to growing pollution levels, the incidence of respiratory disorders is on the rise in India. This has fueled the demand for nebulizers remarkably in the country. In 2014, the India nebulizers market stood at INR575.6 mn. The dramatic growth in the cases of asthma, cystic fibrosis, and chronic obstructive pulmonary diseases is anticipated to boost the adoption of nebulizers among Indian citizens in the coming years. According to experts, the demand for these instruments will rise at a CAGR of 25.80% between 2015 and 2023 and reach an opportunity of INR4,703.4 mn by the end of 2023.
Aptness for all Types of Medications Drive Demand for Pneumatic Nebulizers
In India, the nebulizers market comprises pneumatic nebulizer, mesh nebulizer, ultra-sonic nebulizer, and nebulizer kits. Among these, pneumatic nebulizers are the most demanded product, owing to their aptness for almost all types of medications. In 2014, the pneumatic nebulizers segment held a share of more than 68% in the overall market, reaching to an opportunity worth INR393.53 mn. Expanding at a CAGR of 25.40% between 2015 and 2023, this opportunity is likely to increase to INR3,118.3 mn by 2023.
Mesh nebulizers emerged second in 2014 with a share of nearly 17% in the overall market. Equipped with latest technologies, these nebulizers are highly efficient and perform fast drug delivery, which is why their demand is reported to be increasing significantly. The segment is projected to register a CAGR of 27.1% between 2015 and 2023.
North Zone to Remain Dominant Regional Market for Nebulizers
The India nebulizers market is studied on the basis of its performance in the north zone, east zone, central zone, south zone, and the west zone. In 2014, north zone emerged as the market leader with a share of 35.10%. The increasing prevalence of acute respiratory diseases and chronic obstructive pulmonary disorders, triggered by the escalating level of pollution, has fueled the demand for nebulizers significantly in this zone. Analysts expect a gradual increase in this demand at a CAGR of 27.50% over the period from 2014 to 2023, ensuring the dominance of the north zone during this period.
Nebulizers are also witnessing a high demand in the east zone. According to the department of environment in West Bengal, 70% of people in Kolkata suffer from one or the other form of respiratory conditions, owing the immense environmental pollution. As the pollution continues to rise, the prevalence of respiratory diseases in this zone is projected to witness a considerable increase in the near future, boosting the demand for nebulizers.
Large Participant Pool Makes for Fragmented Competitive Landscape
The nebulizers market in India demonstrates a highly fragmented structure, thanks to the presence of a large pool of participants. Omron Healthcare, Nulife, and Philips Healthcare are at the forefront of this market. Resipirotech Med Solutions Pvt. Ltd., Becton, Dickinson and Co., PARI Respiratory Equipment Inc., Medicare Equipments (India) Pvt. Ltd., Bhasin Sons Private Ltd., Agilent Technologies, Inc., and DeVilbiss Healthcare LLC are some of the other prominent companies operating in this market.

Monday, 19 December 2016

Ambulatory Surgical Centers Growing Popularity Stimulates Demand for Operating Room Equipment, says TMR

Global Operating Room Equipment Market: Snapshot
Operating rooms usually form the bulk of a hospital’s expenses. As such, the companies that provide operating room equipment can gain major revenues by providing for leading names in the healthcare industry. The operating room equipment companies are also becoming rapidly aware of the current market need for reducing costs of equipment to make the market more approachable, while consumers are showing a decline in healthcare expenditure, owing to rising costs and unfavorable healthcare policies and reimbursement schemes.
The advent of hybrid operating rooms is also beneficial to the providers of operating room equipment. Hybrid operating rooms can lend more flexibility to the doctor and the patient as well. They also impart a better level of health safety to the patient and maintaining a high level of operational efficiency. As a result, the global operating room equipment market is progressing at a CAGR of 6.68% from 2015 to 2023. This market was valued at US$23 bn in 2014 and is expected to reach around US$42 bn before the end of 2023.
Medical Tourism Creates High Demand for Operating Room Equipment in APAC
The Asia Pacific sales of operating room equipment have been relatively lower than those in North America and Europe, but this is expected to change over the coming years. This regions is showing a high and optimistic scope for players to expand their portfolio, and one of the key reasons for this is the growth of medical tourism. Patients from developed economies preferring the cheaper medical practices in Asia Pacific have significantly improved the revenue stream of this region, providing a highly attractive market space for global and regional operating room equipment players alike.
The current scope of providing operating room equipment lies in healthcare organizations in the Asia Pacific that offer surgical practices for joint replacement, cosmetics, dental procedures, and cardiac issues. The influx of revenue through medical tourism has also prompted the national governments to invest in this sector, improving the chances of operating room equipment players gaining a solid revenue stream.
North America was the dominant region for operating room equipment revenue generation in 2014, followed by Europe. Both regions have consistently been at the top in terms of using modern medical concepts in advanced healthcare infrastructures. This has allowed key players from the region to put a greater focus on innovation and product improvements, further expanding the scope of revenue generation in these regions.
Movable Imaging Systems to Remain Top Operating Room Equipment Product Segment
In 2014, movable imaging systems as a market segment had garnered over US$6 bn or around 28% of the total revenue. This segment is currently expected to be the fastest growing in terms of revenue. A major reason for this segment’s rapid growth is the high amount of funding provided by government bodies to promote the use of movable imaging systems, especially in North America. Even on a regional level, there are major efforts being taken to modernize hospitals that are supported by state or local organizations.
The segment of operating room integration systems, however, is expected to be the fastest growing segment between 2015 and 2023, owing to a high demand for smart infrastructure and improved connectivity within hospital and medical devices. Key providers of operating room equipment in the world include Stryker Corporation, Steris Corporation, Olympus Corporation, GE Healthcare and Allen Medical.

Thursday, 15 December 2016

Cardiac Rehabilitation Market - Latest Trends & Insights 2024

In the highly consolidated global market for cardiac rehabilitation, innovations and product costs will be major determinants of success, marks a recent report by Transparency Market Research. The top two companies in the market, Brunswick Corporation and Technogym, had a clear hold on the market’s overall growth prospects, accounting for a combined share of over 50% in 2015. Other leading vendors such as Brunswick Corporation, Johnson health Tech Co., and Amer Sports, in combination with these two companies, accounted for a share of nearly 70% in the global market in the same year.
Characterized by high competitive rivalry, high rate of introduction of technologically advanced products, and a continuous rise in global demand, the market for cardiac rehabilitation will emerge as a lucrative investment hub for investors in the years to come.
Rising Global Population of Geriatrics to be Major Driver
The world’s population of people aged more than 60 years is rising at a rapid pace, upping the risk of cardiovascular diseases as aging has a major impact on the body’s cardiovascular system. This factor is also the root cause of the increasing rates of morbidity, disability, mortality, and a substantial rise in the world’s healthcare costs. According to the Institute for Health Metrics and Evaluation, the world’s geriatric population suffered a 55% rise in deaths due to cardiovascular diseases between the period of 1990 and 2013.
WHO statistics, on the other hand, highlight another major concern – the high prevalence of cardiovascular diseases and resultant rise in deaths in developing and underdeveloped countries. Low- and middle-income countries in developing and underdeveloped parts of the globe account for a staggering 82% share in the total number of deaths caused due to non-communicable diseases across the world; of these, cardiovascular diseases account for a massive 37% share. Driven with the aim of improving the situation, sustained efforts for preventing and treating cardiovascular diseases undertaken on national and international levels will have a major impact the global cardiac rehabilitation market in the future.
High Product Costs to Constrain Demand for Cardiac Rehabilitation
Being a highly capital- and research-intensive marketplace, cardiac rehabilitation products, quite naturally, carry a high price tag and always carry the risk of being outclassed by newer and most often technologically advanced products in the market. In this highly dynamic market, where the rate of introduction of technologically advanced varieties of product types is immense, the high and rising costs of cardiac rehabilitation products are a major restraints for further expansion. Cost is a major constraint especially for the market’s growth in developing regions such as Asia Pacific and Latin America.
Apart from the factor of cost, low enrolments in cardiac rehabilitation programs and lack of skilled resources providing cardiac rehabilitation services are also major restraints for the global cardiac rehabilitation market. To overcome the challenge of low enrolments, vendors will have to focus more on formulating programs that have flexible schedules and are sensitively priced according to the region of operation. Intervention from government and private educational institutes will be necessary for increasing the number of rehabilitation counsellors on a global front.
The global market for cardiac rehabilitation had a valuation of US$1,010.93 mn in 2015. It will expand at a healthy 5.4% CAGR from 2016 through 2024 and rise to a valuation of US$1,622.9 mn by 2024.
This analysis of the global cardiac rehabilitation market has been based on a recent market research report, titled “Cardiac Rehabilitation Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 – 2024.”

Monday, 17 October 2016

New Trends of Advanced (3D/4D) Visualization Systems Market with Worldwide Industry Analysis to 2024

The global advanced 3D/4D visualization systems market is dominated by some of the key companies such as Philips Healthcare, Toshiba, Siemens Healthcare, and GE Healthcare. These top companies collective dominated the global advanced 3D/4D visualization systems market by accounting for 39.4% in 2015. The global advanced 3D/4D visualization systems market is highly dynamic and competitive in nature with many new companies aiming to enter the competition. Going forward, the demand for higher technology 3D/4D visualization systems is expected to increase, which will increase the level of competition. Transparency Market Research (TMR), in a new report on this global market, states that the market is expected to be affected by the presence of substitutes for 3D/4D visualization systems.
The global advanced 3D/4D visualization systems market is predicted to reach US$3,280.0 mn by 2024. Based on platform, the global advanced 3D/4D visualization systems market is expected to be dominated by the CT segment as this segment is predicted to reach US$954.5 by 2024. Considering the rising demand, key companies are expected to introduce new 3D and 4D visualization systems in the global market so as to maintain their dominance throughout the forecast period.
Hospitals to Lead Demand for Advanced 3D/4D Visualization Systems
By end user, the global advanced 3D/4D visualization systems market was led by the hospital segment in 2015 and this segment is predicted to maintain its dominance throughout the forecast period. The hospital segment is expected to reach US$2,630.9 mn by 2024 owing to the rising number of hospitals demanding advanced 3D/4D visualization systems. Based on application, neurology led the global advanced 3D/4D visualization systems market in 2015. This segment is expected to maintain its dominance by 2024, to reach US%875.8 mn. The rising use of 3D and 4D visualization systems for conducting oncology procedures is predicted to propel this segment. Based on region, North America dominated the global advanced 3D/4D visualization systems market in 2015 and is predicted to maintain its dominance. The North America advanced 3D/4D visualization systems market is expected to reach US$1,052.9 by 2024.
Rising Medical Procedures to Propel Demand for 3D/4D Visualization Systems
The number of neurology, cardiology, oncology, and many other medical procedures is increasing in many of the emerging nations. “Medical procedures are conducted by using advanced quality 3D and 4D visualization systems, which is a boon for the global market,” says a TMR analyst. Advancements in the existing visualization systems and the rise in the demand for digitizing patient data are two of the other factors expected to benefit the global advanced 3D/4D visualization systems market.
Emergence of 5D Technology can Challenge Global Market
The introduction of 5D visualization technology has become possible because of the introduction of advanced technology. This is expected to be the biggest challenge for the global advanced 3D/4D visualization systems market. The high cost of equipment and the already existing investments in costly medical equipment can also hinder the growth of the global market for advanced 3D/4D visualization systems.
Untapped Market to Create Growth Opportunities
Emerging technologies and the untapped market can create new growth opportunities for the startups and key companies operating in the global advanced 3D/4D visualization systems market. The evolution of new advanced application for AV software is likely to benefit the global market for advanced 3D/4D visualization, says a TMR analyst.
This information is based on the findings of a report published by Transparency Market Research titled “Advanced (3D/4D) Visualization Systems Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016–2024.”

Wednesday, 12 October 2016

Needle-Free Drug Delivery Devices: Increasing Incidence of Needle Stick Injuries Globally Making Needles Needless in Future

With the increasing strategic alliances between needle-free drug delivery devices manufacturers, the business landscape of this market demonstrates a rather consolidated structure. In 2014, the top three companies, namely, Zogenix, 3M, and Antares Pharma Inc., jointly held a share of more than 60% in the overall market, finds Transparency Market Research (TMR) in a new study.
Apart from mergers, acquisitions, and partnerships, leading companies are currently focusing on introducing advanced devices based on novel technologies to strengthen their presence in this market. Looking forward, the vast array of technically advanced devices - in the pipeline at present - will further intensify the competition in the worldwide market for needle-free drug delivery devices in the near future.
Growing Preference for Painless Delivery of Medicines Fuels Demand for Needle-Free Drug Delivery Devices
The growing preference for efficient and painless delivery of medicines is leading the drug delivery market towards needle-free injection systems. As these systems make use of a liquid drug delivery technology that works effectively with already available drug formulations, the development costs on these products are very low. This has encouraged a number of medical devices manufacturers to invest in needle-free drug delivery devices, boosting the market’s growth.
In addition to this, the increasing need to prevent needle-stick injuries is likely to stimulate the adoption of needle-free drug delivery devices significantly during the forecast period. The rising prevalence of infectious diseases such as dengue, hepatitis, and AIDS, and various cardiovascular and neurological diseases, which require continual administration of drugs, is also projected to create substantial demand for these devices over the next few years.
Despite North America’s Dominance, Asia Pacific to Report Fastest Growth
According to TMR’s estimates, the opportunity in the global market for needle-free drug delivery devices that valued at US$5.4 bn in 2014, is likely to increase at a CAGR of 9.90% during the period from 2015 to 2023 and possibly worth US$13 bn by the end of the forecast period.
View exclusive Global strategic Business Report : http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=447
In 2014, North America led the global market with a share of more than 40% and was closely followed by Europe. During the forecast period, North America will remain the dominant regional market; however, it will lose a significant amount of its market shares to Asia Pacific. The latter, on the other hand, will emerge as the fastest growing market for needle-free drug delivery devices in the coming years.
Needle-free drug delivery devices are mostly utilized for the administration of insulin in the human body. The insulin delivery segment has been leading the application segment since the last few years and is projected to remain dominant over the coming years.
Competing needle-fee technologies, such as inhaler, transdermal, and various other novel needle-free technologies witnessed the highest demand in 2014. However, jet injectors are likely to exhibit the fastest growth rate over the forecast period.
The study presented here is based on the findings of a report by TMR, titled, “Needle Free Drug Delivery Devices Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2015 - 2023.”

Friday, 7 October 2016

Implantable Medical Devices Market: Advanced technologies & growth opportunities in global Industry by 2024

The global market for implantable medical devices is expected to witness steady growth, in terms of both volume and revenue, in the next few years. The vast rise in incidence of musculoskeletal, dental, and a vast number of chronic degenerative health conditions are boosting the overall global demand for a variety of implantable medical devices globally. The rising geriatric population, increased affordability, and the trend of increasing expenditures aimed at maintaining health and longevity are also boosting the growth of the global implantable medical devices market globally.
Transparency Market Research estimates that the global implantable medical devices market will expand at a healthy CAGR of 4.9% over the period between 2016 and 2024. At this pace, the market is expected to rise to US$49.8 bn in 2024 from a valuation of US$32.3 bn in 2015.
Titanium Implants to Lose Ground to Titanium Alloys and Zirconium Implants
Of the key materials used for manufacturing implantable medical devices, titanium is presently the largest contributor to the global market’s overall revenues, accounting for a share of 42% in 2015. However, the segment is projected to witness a slight decline in its share in the global market to the segment of titanium alloys over the said period. The segment of titanium implants is expected to exhibit a 4.7% CAGR while the segment of titanium alloy implants is expected to expand at a 5.5% CAGR over the period between 2016 and 2024.
The segment of zirconium implants is expected to emerge as the one with the most promising growth opportunities over the said period. The segment is expected to expand at the fastest CAGR of 6.4% from 2016 to 2024 as compared to other prominently used materials for manufacturing implantable medical devices. The advantage of one-piece zirconium implants that they don’t catch bacterial growth or do not suffer gradual degradation by electrochemical attacks, owing to the absence of any prosthetic connections, is expected to work in their favor and reduce the reliance on titanium implants, which mostly have these disadvantages. The same factor is also expected to work in the favor of titanium alloys and bring a decline in the overall use of titanium for the manufacture of medical implants.
Asia Pacific Implantable Medical Devices Market to Post Considerable Gains
North America is presently the leading contributor to the global implantable medical devices market’s revenues in 2015, accounting for a share of nearly 42%. The region is also expected to retain its dominance in the global market over the forecasting horizon. Factors such as the well-established healthcare facilities, rising geriatric population, effective reimbursement policies, high purchasing power, and rising numbers of obese people will play a key role in bringing this estimate into effect. The U.S. is the most eminent national market for implantable medical devices in the region, accounting for over 92% of the North America IMD market in 2015.
However, the North America market is expected to lose prominence to the Asia Pacific IMD, which is expected to expand at the fastest pace over the period between 2016 and 2024. The factors that are expected to boost the overall consumption of implantable medical devices in Asia Pacific in the next few years include the rising population of affluent consumers, improving healthcare infrastructure, booming medical tourism industry, and rising focus and expenditure on healthcare and wellness.
Japan is the most prominent country for implantable medical devices in Asia Pacific and the second-largest country-wise market across the globe. Japan’s market for implantable medical devices is expected to expand at a favorable pace over the period between 2016 and 2024 as well. Factors such as the country’s vast geriatric population, rising prevalence of orthopedic conditions, and the continuous rise in demand for advanced technologies in the healthcare industry will contribute to the increased demand for implantable medical devices in the country.
The market features a largely consolidated competitive landscape, with the top five companies, including Zimmer Biomet, Johnson & Johnson, Stryker Corporation, Medtronic plc, and Institut
Straumann AG, commanding a more than 50% share of the global market in 2015. Other key vendors in the market include Smith & Nephew plc, Danaher Corporation, Abbott Laboratories, Dentsply Sirona, and Boston Scientific Corporation.

Thursday, 6 October 2016

Hearing Aids Market: Preparing for Commercialization – Timing, Challenges and Solutions

Early detection and treatment of hearing loss can mitigate the severity of deafness and could improve the condition of those suffering from the condition. As per World Health Organization, in 2015 the hearing aid production globally, hardly met 10% of the total need and a meager 3% of demand across developing countries. This provides the global hearing aids market with substantial opportunities to gain from in the forthcoming years.
As per Transparency Market Research (TMR), the global hearing aids market is expected to reach US$7.01 bn by 2024, from US$4.7 bn in 2015. Between 2016 and 2024, the global hearing aids market is thus expected to surge at a CAGR of 4.5%.
Increasing Geriatric Population and Awareness to Boost Sales of Hearing Aids
As aged people are more prone to develop hearing impairment, the sales of hearing aids are directly impacted by the current geriatric demographic dynamics in worldwide. In the last of few years, the awareness level among patients and their families regarding hearing impairment has considerably increased. This, combined with the recent advances in the hearing aid technology, is boosting sales of hearing aids worldwide. Furthermore, the advent of rechargeable hearing aids with long lasting and quick charging features will also augment the market’s growth.
Opportunities for the Market in Europe to be Most Lucrative
Regionally, Europe has been exhibiting the most attractive opportunities for companies in the hearing aids market. It emerged dominant with a share of 39% in the global market in 2015. The presence of a large pool of aged people across Western Europe and the increasing willingness among consumers to spend on advanced medical devices have helped Europe attain the lead in the global hearing aids market. The fact that several of the prominent names in the industry are domiciled in the region has also augured well for the market. TMR has pegged the value of the Europe hearing aids market at US$1.8 bn in 2015 and forecasts it to reach US$2.6 bn by the end of 2024, rising at a CAGR 4.1% from 2015 to 2024.
However, the market in Asia Pacific is expected to grow at a fast pace during the forecast period. The prevalence of considerably high unmet medical needs and the rising investment in the health care infrastructure create immense opportunities for sale of hearing aids in Asia Pacific. Besides this, governments across emerging economies are making considerable efforts to educate people about conditions such as health impairments have fuelled demand for hearing aids in the region. As per TMR, the regional market is expected to rise at a CAGR of 5.2% between 2016 and 2024.
Increasing Incidence of Hearing Loss in Children to Necessitate Development of New Products
By end user, the global hearing aids market is bifurcated into adult and pediatric. Of these, the adult segment held approximately 94.83% of the market in 2015.The incidence of hearing impairment is higher in developing and under-developed countries because of the high geriatric population in these countries. However, in the forecast period growth exhibited by the pediatric segment is expected to be faster due to the rising prevalence of hearing loss among children.
Key players in this market are Sonova AG (Switzerland), William Demant Holding (Denmark), Siemens Healthcare (Germany), GN ReSound A/S (Denmark), Starkey (U.S.), and Widex A/S (Denmark), among others.